Jonathan Halperin, MD
Enriched profileRobert and Harriet Heilbrunn Professor of Medicine; Director, Cardiovascular Fellowship Program, Mount Sinai Fuster Heart Hospital; Vice Chair for Education in Cardiology, Mount Sinai Fuster Heart Hospital · Icahn School of Medicine at Mount Sinai
Jonathan Halperin is Robert and Harriet Heilbrunn Professor of Medicine; Director, Cardiovascular Fellowship Program, Mount Sinai Fuster Heart Hospital; Vice Chair for Education in Cardiology, Mount Sinai Fuster Heart Hospital at Icahn School of Medicine at Mount Sinai. OpenAlex indexes 501 publications with 91,343 citations (h-index 130); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Jonathan Halperin, MD, is Robert and Harriet Heilbrunn Professor of Medicine at Icahn School of Medicine at Mount Sinai / Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, NY. The public record shows 501 publications with 91,343 citations (h-index 130), centered on Atrial Fibrillation. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 6 companies, 1 NIH-funded awards (1994–1998).
- Most recent indexed publication: 2026 · European heart journal. Cardiovascular Imaging
- Top research focus: Atrial Fibrillation
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Member
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗ - Member
Data Safety Monitoring Board, NIH clinical trial of aspirin and simvastatin in pulmonary arterial hypertension
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Genetic Response to Warfarin in Healthy Subjects
Sponsor: Icahn School of Medicine at Mount Sinai
- Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
Sponsor: Biotronik, Inc.
Industry payments
Updated 27 Aug 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Bioventus LLCProgram year20251 payment
- Bioventus LLCProgram year20241 payment
- Janssen Pharmaceuticals, IncProgram year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.2%Statin22.8%Atorvastatin Calcium62%Rosuvastatin Calcium25%Simvastatin6%Pravastatin Sodium4%Livalo2%Part D<11 patientsBeta blocker18.8%Metoprolol Succinate44%Carvedilol23%Atenolol17%Bisoprolol Fumarate9%Nebivolol Hcl8%Part D<11 patientsBlood & clotting
17.4%Factor Xa inhibitor12.7%Eliquis68%Xarelto32%Part D≥50 patientsP2Y12 inhibitor2%Clopidogrel100%Part D≥16 patientsMetabolism & gastrointestinal
2.4%SGLT2 inhibitor1.7%Jardiance100%Part D≥11 patientsPotassium supplement0.6%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 1994–1998 per NIH RePORTER. The latest:
- TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN ATRIAL FIBRILLATION
Mount Sinai School of Medicine of Nyu
FY1998R01NS033351 - TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN ATRIAL FIBRILLATION
Mount Sinai School of Medicine of Nyu
FY1997R01NS033351 - TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN ATRIAL FIBRILLATION
Mount Sinai School of Medicine of Cuny
FY1996R01NS033351
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Impact of Atrial Fibrillation in Patients With Severe Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.
Journal of the American Heart Association
Article2025 - Association of Systemic Inflammatory Response Syndrome With Cardiovascular Events After Mitral Transcatheter Edge-to-Edge Repair.
Journal of the American Heart Association
Article2024 - Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF Analysis.
Journal of the American Heart Association
Clinical Trial2024 - Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness.
Journal of the American Heart Association
Clinical Trial2022
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/jonathan-halperin-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
esc365.escardio.org/person/67330
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →esc365.escardio.org ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - LinkedIn
LinkedIn profile listing employer as Mount Sinai Medical Center (page auth-walled; corroborated via SERP snippet only, not opened)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- Board certified
Cardiovascular Disease and Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Fellow
American College of Cardiology (F.A.C.C.)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗ - Fellow
American Heart Association (F.A.H.A.)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗
Editorial & leadership roles
journal and society appointments- Deputy Editor
Journal of the American College of Cardiology (JACC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗ - Former Chair
ACC/AHA Task Force on Practice Guidelines
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗ - Former Chair
ACC/AHA/ACP Task Force on Clinical Competence and Training
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cpcclinicalresearch.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
Andrea Dunaif, MD
Icahn School of Medicine at Mount Sinai